DOCSLIB.ORG

European Market Outlook - 28 May 2021

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
European Market Outlook - 28 May 2021 European Market Outlook - 28 May 2021 The STOXX 600 index, which monitors the performance of Siemens rose more than 3.5 percent in Germany. With the top publicly traded firms in 17 European nations, was sharp to moderate increases, Lufthansa, Infineon up 0.27 percent at 446.44. Technologies, Merck, MTU Aero Engines, Munich RE, BASF, Allianz, SAP, and Deutsche Bank completed the The German DAX declined by 0.28 percent to 15,406.73. day. Daimler, BMW, Deutsche Post, Fresenius Medical France's CAC 40 gained 0.75%, while the U.K.'s FTSE Care, and Thyssenkrupp all finished the quarter with 100 edged up 0.04%. Switzerland's SMI ended 0.76% up. disappointing results. In the UK, Taylor Wimpey, Croda International, Persimmon, In economic news, the European Commission's economic Barratt Developments and Scottish Mortgage gained 2.3 to mood index rose sharply to 114.5 in May, up from 110.5 in 2.6%. Berkeley Group Holdings, Burberry Group, Melrose April and far above the 112.1 forecast. Industries, HSBC Holdings, Standard Chartered, ICP and Bunzl also rose sharply. Antofagasta, Evraz, Ashtead Group, Ocado Group, Polymetal International, Fresnillo, and British American Tobacco, on the other hand, all fell between 1.7 and 2.2 percent. In the French market, Air France-KLM climbed more than 2.5%. Kering, AXA, LOreal, Credit Agricole, WorldLine, STMicroElectronics, Safran, Sanofi and Airbus gained 1 to 2%. Top Gainers Top Losers CODE Last Price Change% Company Last Price Change% SES €6.83 +5.42% Banco De Sabadell €0.631 -6.54% Beijer Ref €141.50 +4.43% Holmen €379.42 -5.42% NEL ASA €18.29 +4.37% Corbion €47.34 -4.17% AMBU €232.9 +4.25% Marks & Spencer €165.40 -3.33% JC Decaux €24.04 +4.07% Royal Mail €578.60 -2.85% Market Outlook- 28 May 2021 Disclaimer and General Advice Instructions: This document is provided by Laverne Securities Pty Ltd T/as La Verne Investing the Corporate Authorized Representative No. CAR No. 001269781 of La Verne Capital Pty Ltd AFSL 482937. The Research Analyst who prepared this report/article hereby certifies that the views expressed in this document accurately reflect the analyst’s personal views about the Company and its financial products. The information provided in the Report/Article is provided by Morningstar and FactSet. La Verne Fund is not a fund manager, however, the portfolio and the document is for general advice only, prepared by the Analysts and Research team for our clients. This report/article have Different Assumptions, Views, Analytical Method of the analyst with no guarantee of reliability and accuracy of the content. The Research Analyst has not been, is not, and will not be receiving direct or indirect compensation for expressing the specific recommendations or views in this report/article. La Verne Securities has its own Research methodology, with regards to the rating and is confirmed by the team for long term Strategic rating of the concerned security as an Investment for Portfolios with High Growth High Risk Profile. Individual Stock is Speculative and of High Risk in nature and strongly This Document is provided for the Advisors, their Clients, and Financial Professionals for information only and should not be considered an offer or solicitation of an offer to buy or sell a particular security or financial product or instrument. The information or services provided in this report/article may not be suitable for you and we strongly recommend taking the advice of your Financial Planner or Investment advisors. Laverne Investing will not treat the recipients as its customer by virtue of their receiving the report/article and should seek the advice of their consultant, prior to making any investment decision considering this report/article.
Load more

Recommended publications
  • PRESS RELEASE Safran Announces the Availability of Its 2021 Interim
    PRESS RELEASE Safran announces the availability of its 2021 Interim Financial Report Paris, August 4, 2021 Safran (Euronext Paris: SAF) has filed the French version of its 2021 Interim Financial Report (Rapport Financier Semestriel) with the French financial markets authority (Autorité des marchés financiers – AMF). From August 4 2021, this document (PDF) can be viewed on or downloaded from: Safran’s website, at www.safrangroup.com under the heading “Finance”/sub-heading “Publications”, The French Financial Markets Authority’s website, at www.amf-france.org Agenda Q3 2021 revenue October 29, 2021 Capital Markets Day 2021 December 2, 2021 2021 annual results February 24, 2021 * * * * * Safran is an international high-technology group, operating in the aviation (propulsion, equipment and interiors), defense and space markets. Its core purpose is to contribute to a safer, more sustainable world, where air transport is more environmentally friendly, comfortable and accessible. Safran has a global presence, with 76,000 employees and sales of 16.5 billion euros in 2020, and holds, alone or in partnership, world or regional leadership positions in its core markets. Safran undertakes research and development programs to maintain the environmental priorities of its R&T and Innovation roadmap. Safran is listed on the Euronext Paris stock exchange and is part of the CAC 40 and Euro Stoxx 50 indices. For more information : www.safran-group.com / Follow @Safran on Twitter Press Catherine Malek : [email protected] / T +33 (0)1 40
    [Show full text]
  • OPTIMAL VALUE R Eurozone Value Equity ISIN FR0012144590 MONTHLY REPORT AUGUST 31, 2021
    MANDARINE OPTIMAL VALUE R Eurozone Value Equity ISIN FR0012144590 MONTHLY REPORT AUGUST 31, 2021 Risk profile 1 2 3 4 5 6 7 Mandarine Optimal Value selects eurozone companies with two specific characteristics: stocks that are undervalued by the market and offer an improving financial and extra- financial outlook (positive momentum). +2.7% +24.2% 16.9% Performance Performance Volatility 1 month YTD 1 year PERFORMANCES AND RISKS The data presented relates to past periods, past performance is not an indicator of future results. Bench. Bench. Bench. +2.6% +20.3% 16.9% Statistical indicators are calculated on a weekly basis. Benchmark: EuroStoxx Large NR Evolution since inception 162.13EUR Fund Bench. Net asset value 80% Yohan Florian SALLERON ALLAIN 60% Even if some fears persist regarding the pace of future growth (thereby favouring stocks with 40% generally defensive profiles over the month), the eurozone stock markets pursued their rebounds, 20% consequently showing solid annual gains. 0% As could be expected, the best contributors to the fund’s performance over the month included -20% healthcare (Merck, Eurofins scientific) and public 2015 2016 2017 2018 2019 2020 2021 services (Verbund). Our luxury goods stocks (LVMH, Moncler and Kering) suffered in August due to Chinese Annual performances statements evoking the idea of a better distribution of wealth in China. Fund Bench. 30% Despite the rather cyclical bias in our portfolio, +26.5 +24.2 which we are maintaining due to these stocks’ +20.3 +16.3 good financial momentum (which is not 15% +12.3 +10.8 weakening), the fund nevertheless succeeded in +6.2 slightly outperforming its benchmark index over +4.0 the month, thereby adding to its cumulative 0% outperformance since the beginning of the year.
    [Show full text]
  • Liste Des Actions Concernées Par L'interdiction De Positions Courtes Nettes
    Liste des actions concernées par l'interdiction de positions courtes nettes L’interdiction s’applique aux actions listées sur une plate-forme française et relevant de la compétence de l’AMF au titre du règlement 236/2012 (information disponible dans les registres ESMA). Cette liste est fournie à titre informatif. L'AMF n'est pas en mesure de garantir que le contenu disponible est complet, exact ou à jour. Compte tenu des diverses sources de données sous- jacentes, des modifications pourraient être apportées régulièrement. Isin Nom FR0010285965 1000MERCIS FR0013341781 2CRSI FR0010050773 A TOUTE VITESSE FR0000076887 A.S.T. GROUPE FR0010557264 AB SCIENCE FR0004040608 ABC ARBITRAGE FR0013185857 ABEO FR0012616852 ABIONYX PHARMA FR0012333284 ABIVAX FR0000064602 ACANTHE DEV. FR0000120404 ACCOR FR0010493510 ACHETER-LOUER.FR FR0000076861 ACTEOS FR0000076655 ACTIA GROUP FR0011038348 ACTIPLAY (GROUPE) FR0010979377 ACTIVIUM GROUP FR0000053076 ADA BE0974269012 ADC SIIC FR0013284627 ADEUNIS FR0000062978 ADL PARTNER FR0011184241 ADOCIA FR0013247244 ADOMOS FR0010340141 ADP FR0010457531 ADTHINK FR0012821890 ADUX FR0004152874 ADVENIS FR0013296746 ADVICENNE FR0000053043 ADVINI US00774B2088 AERKOMM INC FR0011908045 AG3I ES0105422002 AGARTHA REAL EST FR0013452281 AGRIPOWER FR0010641449 AGROGENERATION CH0008853209 AGTA RECORD FR0000031122 AIR FRANCE -KLM FR0000120073 AIR LIQUIDE FR0013285103 AIR MARINE NL0000235190 AIRBUS FR0004180537 AKKA TECHNOLOGIES FR0000053027 AKWEL FR0000060402 ALBIOMA FR0013258662 ALD FR0000054652 ALES GROUPE FR0000053324 ALPES (COMPAGNIE)
    [Show full text]
  • Safran Aircraft Engines Download
    SAFRAN AIRCRAFT ENGINES This is a multi-site certificate, additional site details are listed in the appendix to this certificate 10 ALLEE DU BREVENT - COURCOURONNES 91019 EVRY CEDEX - FRANCE Bureau Veritas Certification certify that the Management System of the above organisation has been audited in accordance with the relevant Aerospace Supplier Quality system Certification Scheme EN 9104-001:2013 and found to be in accordance with the requirements of the management system standard detailed below: Standard EN 9100:2018 AS 9100:D - JISQ 9100:2016 Scope of certification DESIGN, DEVELOPMENT, PRODUCTION, DISTRIBUTION, TEST AND SERVICING OF CIVIL AND MILITARY AIRCRAFT ENGINES - DESIGN, DEVELOPMENT, PRODUCTION, DISTRIBUTION, TEST AND SERVICING SATELLITE AND SPACECRAFT PROPULSION SYSTEMS - ASSOCIATED SERVICES PROVIDED TO CIVIL AND MILITARY CUSTOMERS. Certification structure : Campus Certification Issue date: 15 September 2018 Subject to the continued satisfactory operation of the organization’s Management System, this certificate expires on (Certification Expiry date): 14 September 2021 Original certification date: 15 July 2004 Certificate : 7098050-Rev0 Date: 06 September 2018 File number : FR044707-1 Jacques Matillon – Managing DIrector Bureau Veritas Certification France 60, avenue du Général de Gaulle – Immeuble Le Guillaumet - 92046 Paris La Défense Further clarifications regarding the scope of this certificate the applicability of the management system requirements may be obtained by consulting the organization. To check this certificate validity, please call + 33(0) 1 41 97 00 60. APPENDIX SAFRAN AIRCRAFT ENGINES Standard EN 9100:2018 AS 9100:D - JISQ 9100:2016 Scope of certification Site Address Scope 10 ALLEE DU BREVENT COURCOURONNES SIEGE CENTRAL FUNCTIONS 91019 EVRY CEDEX, France RUE HENRI AUGUSTE INDUSTRIALIZATION AND MANUFACTURING OF PARTS AND EVRY-CORBEIL DESBRUÈRES - BP 81 COMPONENTS FOR AIRCRAFT ENGINES.
    [Show full text]
  • BIODIVERSITY STRATEGY Bending the Curve on Biodiversity Loss KERING BIODIVERSITY STRATEGY
    BIODIVERSITY STRATEGY Bending the Curve on Biodiversity Loss KERING BIODIVERSITY STRATEGY FOREWORD “How we solve the ongoing environmental crisis is likely the biggest challenge facing our generation. Given the scale of biodiversity loss sweeping the planet, we must take bold action. As businesses, we need to safeguard nature within our own supply chains, as well as champion transformative actions far beyond them to ensure that humanity operates within planetary boundaries. At Kering, our Houses’ products begin their lives in farms, fields, forests and other ecosystems around the world. The careful stewardship of these landscapes is fundamental to our continued success, and also linked to our responsibility on a broader global scale. With Kering’s biodiversity strategy, we are proud to put forth concrete targets to play our part in bending the curve on biodiversity loss, and helping to chart a course for our industry.” François-Henri Pinault Chief Executive Officer, Kering 1 KERING BIODIVERSITY STRATEGY CONTENTS Our Planet In Peril – p.03 Our Commitment – p.04 A Paradigm Shift – p.05 Taking Stock of Progress at Kering – p.06 Taking Action: Aligning To The Science Based Targets Network – p.07 Value Chain Mapping & Materiality Assessments – p.08 Environmental Profit & Loss (EP&L) Accounting – p.09 The Biodiversity Impact Metric – p.09 The Guiding Framework Stage 1: Avoid – p.10 Stage 2: Reduce – p.13 Stage 3: Restore & Regenerate – p.16 Stage 4: Transform – p.20 Monitoring, Reporting & Verification– p.23 Final Thoughts – p.23 References – p.24 Acknowledgements We wish to thank the many external reviewers who provided critical feedback to strengthen this strategy.
    [Show full text]
  • French Aeronautical Players to Fly 100% Alternative Fuel on Single-Aisle Aircraft End of 2021
    French aeronautical players to fly 100% alternative fuel on single-aisle aircraft end of 2021 Toulouse, Paris, 10 June 2021- Airbus, Safran, Dassault Aviation, ONERA and Ministry of Transport are jointly launching an in-flight study, at the end of 2021, to analyse the compatibility of unblended sustainable aviation fuel (SAF) with single-aisle aircraft and commercial aircraft engine and fuel systems, as well as with helicopter engines. This flight will be made with the support of the “Plan de relance aéronautique” (the French government‘s aviation recovery plan) managed by Jean Baptiste Djebbari, French Transport Minister. Known as VOLCAN (VOL avec Carburants Alternatifs Nouveaux), this project is the first time that in-flight emissions will be measured using 100% SAF in a single-aisle aircraft. Airbus is responsible for characterising and analysing the impact of 100% SAF on-ground and in- flight emissions using an A320neo test aircraft powered by a CFM LEAP-1A engine1. Safran will focus on compatibility studies related to the fuel system and engine adaptation for commercial and helicopter aircraft and their optimisation for various types of 100% SAF fuels. ONERA will support Airbus and Safran in analysing the compatibility of the fuel with aircraft systems and will be in charge of preparing, analysing and interpreting test results for the impact of 100% SAF on emissions and contrail formation. In addition, Dassault Aviation will contribute to the material and equipment compatibility studies and verify 100% SAF biocontamination susceptibility. The various SAFs used for the VOLCAN project will be provided by TotalEnergies. Moreover, this study will support efforts currently underway at Airbus and Safran to ensure the aviation sector is ready for the large-scale deployment and use of SAF as part of the wider initiative to decarbonise the industry.
    [Show full text]
  • AXA Rosenberg European Fund
    SHORT REPORT YEAR ENDING 31 JANUARY 2018 ROSENBERG EQUITES AXA Rosenberg European Fund Investment objective and policy AXA Investment The aim of the Fund is to achieve medium to long term capital growth above that of the MSCI Europe ex-UK Index on a rolling three to five year basis. Managers (AXA IM) The MSCI Europe ex-UK Index is designed to measure the performance of the shares of companies is a dedicated listed on stock exchanges in developed European countries (excluding the UK). investment manager The Fund invests in a diversified portfolio of shares of large and medium sized companies in all industry sectors which are listed on European stock exchanges (excluding those in the UK). The Fund within the AXA manager uses a proprietary stock selection model to identify companies that it believes to be attractive, relative to their industry peers, based on the model's analysis of their financial data. In Group, a world constructing the Fund's portfolio, the Fund manager references the index which means that, while the Fund manager has discretion to select the investments for the Fund, the Fund's divergence from the leader in financial index is controlled. protection and The Fund may use derivatives (financial instruments that derive their value from the value of other wealth assets) in an attempt to reduce the overall risk of its investments, reduce the costs of investing or generate additional capital or income known as Efficient Portfolio Management (EPM). management. Rosenberg Equities is AXA IM’s systematic Rosenberg Equities investment process fundamental equity investment specialist, Rosenberg Equities core investment belief has remained unchanged since the formation of the and deploys a pioneering and unique company in 1985.
    [Show full text]
  • SAFRAN ROTORCRAFT SOLUTIONS 2021 PROPULSION SYSTEMS Safran Helicopter Engines Safran Transmission Systems Safran Electronics & Defense
    SAFRAN ROTORCRAFT SOLUTIONS 2021 PROPULSION SYSTEMS Safran Helicopter Engines Safran Transmission Systems Safran Electronics & Defense ELECTRICAL POWER SYSTEMS Safran Electrical & Power Safran Power Units LANDING AND BRAKING SYSTEMS Safran Landing Systems AVIONICS SYSTEMS AND FLIGHT CONTROLS Safran Electronics & Defense AEROSYSTEMS Safran Aerosystems SEATS Safran Seats Photo credits: cover: Anthony Pecchi/Safran - p. 4: Philipp Franceschini/Airbus Helicopters, Philippe Stroppa/Safran - p. 5: Jean-Pascal Donnot - p. 6: Philippe Stroppa/Safran, Cyril Abad/CAPA Pictures/Safran, Thomas Garza/Safran - p. 8: Jean-Pascal Donnot - p. 9: Philippe Stroppa/Safran - p. 10: Anthony Pecchi/Airbus Helicopters - p. 12: Jean-Pascal Donnot - p. 13: Anthony Pecchi/Airbus Helicopters, Eric Drouin/Safran - p. 14: Patrick Penna / Airbus Helicopter - p. 15: Krasker-Studio / Safran, Airbus Helicopters - p. 16: Cyril Abad / CAPA Pictures / Safran - p. 17: Cyril Abad / CAPA Pictures / Safran - p. 18: Ricardo Funari/CAPA Pictures/Safran. 2 SAFRAN OVERVIEW SAFRAN IS AN INTERNATIONAL HIGH-TECHNOLOGY GROUP, OPERATING IN THE AVIATION (PROPULSION, EQUIPMENT AND INTERIORS), DEFENSE AND SPACE MARKETS. ITS CORE PURPOSE IS TO CONTRIBUTE TO A SAFER, MORE SUSTAINABLE WORLD, WHERE AIR TRANSPORT IS MORE ENVIRONMENTALLY FRIENDLY, COMFORTABLE AND ACCESSIBLE. SAFRAN HAS A GLOBAL PRESENCE, WITH 79,000 EMPLOYEES AND SALES OF 16.5 BILLION EUROS IN 2020 AND HOLDS, ALONE OR IN PARTNERSHIP, WORLD OR REGIONAL LEADERSHIP POSITIONS IN ITS CORE MARKETS. SAFRAN UNDERTAKES RESEARCH AND DEVELOPMENT
    [Show full text]
  • Portfolio of Investments
    PORTFOLIO OF INVESTMENTS Variable Portfolio – Partners International Growth Fund, September 30, 2020 (Unaudited) (Percentages represent value of investments compared to net assets) Investments in securities Common Stocks 99.4% Common Stocks (continued) Issuer Shares Value ($) Issuer Shares Value ($) Argentina 1.1% France 9.9% (a) MercadoLibre, Inc. 11,044 11,954,909 Air Liquide SA 33,000 5,230,820 Australia 3.3% Airbus Group SE(a) 115,226 8,356,836 Aristocrat Leisure Ltd. 382,096 8,332,956 Capgemini SE 100,870 12,941,155 Atlassian Corp. PLC, Class A(a) 34,922 6,348,471 Dassault Systemes 30,100 5,616,121 Cochlear Ltd. 21,100 3,014,527 L’Oreal SA 53,085 17,275,402 CSL Ltd. 90,068 18,605,054 LVMH Moet Hennessy Louis Vuitton SE 60,510 28,312,668 Total 36,301,008 Safran SA(a) 109,109 10,734,920 Canada 3.6% Sartorius Stedim Biotech 23,028 7,948,411 Alimentation Couche-Tard, Inc., Class B 179,500 6,250,922 Teleperformance SA 26,943 8,306,583 Brookfield Asset Management, Inc., Class A 129,004 4,264,872 Total SE 113,620 3,902,001 Canadian National Railway Co. 187,926 20,014,109 Total 108,624,917 Dollarama, Inc. 223,415 8,563,780 Germany 5.5% Total 39,093,683 Adidas AG(a) 18,700 6,039,018 China 9.0% Infineon Technologies AG 652,214 18,383,168 Alibaba Group Holding Ltd.(a) 950,520 34,894,654 Rational AG 13,768 10,799,191 CNOOC Ltd.
    [Show full text]
  • FTSE Developed Europe
    2 FTSE Russell Publications 19 August 2021 FTSE Developed Europe Indicative Index Weight Data as at Closing on 30 June 2021 Index weight Index weight Index weight Constituent Country Constituent Country Constituent Country (%) (%) (%) 1&1 AG 0.01 GERMANY Avast 0.03 UNITED Cnp Assurance 0.02 FRANCE 3i Group 0.14 UNITED KINGDOM Coca-Cola HBC AG 0.06 UNITED KINGDOM Aveva Group 0.05 UNITED KINGDOM A P Moller - Maersk A 0.1 DENMARK KINGDOM Coloplast B 0.19 DENMARK A P Moller - Maersk B 0.15 DENMARK Aviva 0.19 UNITED Colruyt 0.03 BELGIUM A2A 0.03 ITALY KINGDOM Commerzbank 0.07 GERMANY Aalberts NV 0.05 NETHERLANDS AXA 0.43 FRANCE Compagnie Financiere Richemont SA 0.55 SWITZERLAND ABB 0.51 SWITZERLAND B&M European Value Retail 0.06 UNITED Compass Group 0.33 UNITED KINGDOM ABN AMRO Bank NV 0.04 NETHERLANDS KINGDOM BAE Systems 0.21 UNITED Acciona S.A. 0.03 SPAIN Continental 0.14 GERMANY KINGDOM Accor 0.06 FRANCE ConvaTec Group 0.05 UNITED Baloise 0.06 SWITZERLAND Ackermans & Van Haaren 0.03 BELGIUM KINGDOM Banca Mediolanum 0.02 ITALY ACS Actividades Cons y Serv 0.06 SPAIN Covestro AG 0.1 GERMANY Banco Bilbao Vizcaya Argentaria 0.36 SPAIN Adecco Group AG 0.09 SWITZERLAND Covivio 0.04 FRANCE Banco Santander 0.58 SPAIN Adevinta 0.04 NORWAY Credit Agricole 0.14 FRANCE Bank Pekao 0.03 POLAND Adidas 0.63 GERMANY Credit Suisse Group 0.22 SWITZERLAND Bankinter 0.03 SPAIN Admiral Group 0.08 UNITED CRH 0.35 UNITED Banque Cantonale Vaudoise 0.02 SWITZERLAND KINGDOM KINGDOM Barclays 0.35 UNITED Adyen 0.62 NETHERLANDS Croda International 0.12 UNITED KINGDOM KINGDOM Aegon NV 0.06 NETHERLANDS Barratt Developments 0.09 UNITED Cts Eventim 0.03 GERMANY Aena SME SA 0.1 SPAIN KINGDOM Cyfrowy Polsat SA 0.02 POLAND Aeroports de Paris 0.03 FRANCE Barry Callebaut 0.07 SWITZERLAND Daimler AG 0.66 GERMANY Ageas 0.09 BELGIUM BASF 0.64 GERMANY Danone 0.37 FRANCE Ahold Delhaize 0.26 NETHERLANDS Bayer AG 0.53 GERMANY Danske Bank A/S 0.1 DENMARK AIB Group 0.02 IRELAND Bechtle 0.04 GERMANY Dassault Aviation S.A.
    [Show full text]
  • MAJOR PROGRAMS Safran Landing Systems Supplies Equipment, Systems and Services to an Extensive Range of Customers and Aircraft Programs
    LANDING SYSTEMS MAJOR PROGRAMS Safran Landing Systems supplies equipment, systems and services to an extensive range of customers and aircraft programs. Landing Landing gear Monitoring Steering Braking Wheels and MRO gear extension/ system system system brakes (including JVs) retraction system LARGE COMMERCIAL AIRCRAFT Airbus A318/A319/A320 GGGGGGG Airbus A321 GGGGG#G Airbus A320neo GGGGGGG Airbus A321neo GGGGGGG Airbus A300/A310 GGGGGGG Airbus A330/A340 GGGGG#G Airbus A330neo GG GG#G Airbus A350 XWB MLG 900 GGGGGG Airbus A380 NLG GGG G Boeing 737 Next-Generation GG Boeing 737 MAX GG Boeing 767 GG Boeing 777LR and 777-8/-9 GGG Boeing 787-8/787-9 GG GG Boeing 747-400 G Boeing 747-8 G REGIONAL AIRCRAFT ATR 42/72 GGG GG Bombardier Dash 8 G G Bombardier CRJ200 G G Sukhoi Superjet 100* GG G G # Messier-Goodrich or Goodrich-Messier JV according to Airline Continued on reverse side > *Also responsible for landing gear system integration Follow us on: www.safran-landing-systems.com @SafranLandingS Safran Landing Systems Landing Landing gear Monitoring Steering Braking Wheels and MRO gear extension/ system system system brakes (including JVs) retraction system HELICOPTERS Airbus Helicopters Alouette III G Airbus Helicopters Dauphin GG GGGG Airbus Helicopters EC175 G Airbus Helicopters Puma GG G GG Airbus Helicopters Super Puma GG G GG Airbus Helicopters Tigre GG G GG Airbus Helicopters H160 GG Sikorsky S-92 G BUSINESS JETS Dassault Falcon GGGGGGG Dassault F7X /F8X * GGGG G Bombardier CRJ/850 GGGG Bombardier Challenger 300/350 GGGG G Bombardier
    [Show full text]
  • June 22, 2020 CURRICULUM VITAE HOWARD SAFRAN, MD Business
    June 22, 2020 CURRICULUM VITAE HOWARD SAFRAN, MD Business or Mailing Address: The Rhode Island Hospital 593 Eddy Street Providence, RI 02903 Business Phone Number: 401-444-4830 Business Fax Number: 401-444-8441 Email: [email protected] Clinical Sites: The Rhode Island Hospital The Miriam Hospital Newport Hospital EDUCATION Undergraduate: 1979-1983 Boston University B.S. Biology, 6/83 Phi Beta Kappa Summa cum laude Medical School: 1983-1987 Boston University MD, 6/87 AOA HONORARY DEGREES: Master of Arts Ad Eundum Brown University 2003 POST GRADUATE AWARDS: Award for outstanding teacher Hematology Oncology Fellowship Brown University 2007 POST GRADUATE TRAINING Internship/Residency 1987-1990 Internal Medicine The Boston University Medical Center Boston, Massachusetts Fellowship: 1990-1993 Hematology/Oncology The Boston University Medical Center Boston, Massachusetts 1 PROFESSIONAL LICENSES AND BOARD CERTIFICATION Certification: 1990 - Diplomate, American Board of Internal Medicine (ABIM) 1994 - Diplomate, Oncology, ABIM 1995 - Diplomate, Hematology, ABIM 2000 Recertified, Internal Medicine 2004 Recertified Hematology and Oncology 2013 Recertified Oncology 2013 Recertified Hematology Licensure: 1990 - Commonwealth of Massachusetts 1993 - State of Rhode Island HOSPITAL APPOINTMENTS 1993 - The Miriam Hospital Department of Medicine Division of Hematology/Oncology 1995 - Co-Chairman Gastrointestinal Oncology Brown University Oncology Group 1997- The Rhode Island Hospital Department of Medicine 2001 - Rhode Island Hospital Clinical Director
    [Show full text]